Wednesday, November 06, 2024 8:59:05 PM
Hi, you’re pretty knowledgeable about the company. The trial was just updated yesterday to active and no longer recruiting. Do you think that the company was delaying their earnings call because of this? If yes, do you think we will receive a milestone because of this?thank you very much I’m bullish
Recent LCTX News
- Lineage Announces Formation of Scientific Advisory Board • Business Wire • 04/13/2026 12:00:00 PM
- Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease • Business Wire • 03/24/2026 12:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/24/2026 04:15:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 08:05:10 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/11/2026 01:00:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2026 01:00:26 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/11/2026 01:00:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2026 12:51:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2026 12:50:33 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 09:10:24 PM
- Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update • Business Wire • 03/05/2026 09:01:00 PM
- Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026 • Business Wire • 02/26/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2026 12:30:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2026 12:30:03 AM
- Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience • Business Wire • 01/06/2026 01:00:00 PM
- Lineage Cell Therapeutics Issues Letter to Stockholders • Business Wire • 01/05/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2025 02:55:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2025 02:55:03 AM
- Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy • PR Newswire (Canada) • 12/16/2025 04:53:00 PM
- Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy • PR Newswire (US) • 12/16/2025 04:53:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2025 09:05:24 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 11/14/2025 11:12:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 02:25:41 PM
